AAAAAA

   
Results: 1-19 |
Results: 19
STANDARDS OF LABORATORY PRACTICE - ANTIEPILEPTIC DRUG-MONITORING
Authors: WARNER A PRIVITERA M BATES D
Citation: A. Warner et al., STANDARDS OF LABORATORY PRACTICE - ANTIEPILEPTIC DRUG-MONITORING, Clinical chemistry, 44(5), 1998, pp. 1085-1095
INCREASED SEIZURE FREQUENCY ASSOCIATED WITH FELBAMATE WITHDRAWAL IN ADULTS
Authors: WELTY TE PRIVITERA M SHUKLA R
Citation: Te. Welty et al., INCREASED SEIZURE FREQUENCY ASSOCIATED WITH FELBAMATE WITHDRAWAL IN ADULTS, Archives of neurology, 55(5), 1998, pp. 641-645
AFFECTIVE-ILLNESS AND EPILEPSY
Authors: KAPLAN M PRIVITERA M
Citation: M. Kaplan et M. Privitera, AFFECTIVE-ILLNESS AND EPILEPSY, The Journal of clinical psychiatry, 58(11), 1997, pp. 498-498
COMPLEX PARTIAL STATUS EPILEPTICUS
Authors: PRIVITERA M
Citation: M. Privitera, COMPLEX PARTIAL STATUS EPILEPTICUS, Neurology, 48(4), 1997, pp. 1140-1141
LONG-TERM EXPERIENCE WITH TOPIRAMATE AS ADJUNCTIVE THERAPY AND AS MONOTHERAPY IN PATIENTS WITH PARTIAL ONSET SEIZURES - RETROSPECTIVE SURVEY OF OPEN-LABEL TREATMENT
Authors: ROSENFELD WE SACHDEO RC FAUGHT RE PRIVITERA M
Citation: We. Rosenfeld et al., LONG-TERM EXPERIENCE WITH TOPIRAMATE AS ADJUNCTIVE THERAPY AND AS MONOTHERAPY IN PATIENTS WITH PARTIAL ONSET SEIZURES - RETROSPECTIVE SURVEY OF OPEN-LABEL TREATMENT, Epilepsia, 38, 1997, pp. 34-36
THE USE OF LANGUAGE AND FRONTAL-LOBE MEASURES FOR PREDICTING EPILEPTOGENIC LESION LOCATION
Authors: DUIS C SCHEFFT BK KIDWELL C YEH HS PRIVITERA M
Citation: C. Duis et al., THE USE OF LANGUAGE AND FRONTAL-LOBE MEASURES FOR PREDICTING EPILEPTOGENIC LESION LOCATION, Archives of clinical neuropsychology, 11(5), 1996, pp. 385-385
TOPIRAMATE PLACEBO-CONTROLLED DOSE-RANGING TRIAL IN REFRACTORY PARTIAL EPILEPSY USING 600-MG, 800-MG, AND 1,000-MG DAILY DOSAGES
Authors: PRIVITERA M FINCHAM R PENRY J REIFE R KRAMER L PLEDGER G KARIM R BOURGEOIS B CARTER G FERRENDELLI J FINCHAM R FROMM G GALLAGHER B HARNER R HOLMES M LEROY R PENRY J PRIVITERA M ROSENFELD W ROWAN A SACKELLARES JC SMITH D WILLMORE L WYLER A
Citation: M. Privitera et al., TOPIRAMATE PLACEBO-CONTROLLED DOSE-RANGING TRIAL IN REFRACTORY PARTIAL EPILEPSY USING 600-MG, 800-MG, AND 1,000-MG DAILY DOSAGES, Neurology, 46(6), 1996, pp. 1678-1683
POSTICTAL LANGUAGE DYSFUNCTION IN PATIENTS WITH RIGHT OR BILATERAL HEMISPHERIC LANGUAGE LOCALIZATION
Authors: PRIVITERA M KOHLER C CAHILL W YEH HS
Citation: M. Privitera et al., POSTICTAL LANGUAGE DYSFUNCTION IN PATIENTS WITH RIGHT OR BILATERAL HEMISPHERIC LANGUAGE LOCALIZATION, Epilepsia, 37(10), 1996, pp. 936-941
ACUTE PHENYTOIN TOXICITY FOLLOWED BY SEIZURE BREAKTHROUGH FROM A TICLOPIDINE-PHENYTOIN INTERACTION
Authors: PRIVITERA M WELTY TE
Citation: M. Privitera et Te. Welty, ACUTE PHENYTOIN TOXICITY FOLLOWED BY SEIZURE BREAKTHROUGH FROM A TICLOPIDINE-PHENYTOIN INTERACTION, Archives of neurology, 53(11), 1996, pp. 1191-1192
DOSE-RANGING TRIAL WITH HIGHER DOSES OF TOPIRAMATE IN PATIENTS WITH RESISTANT PARTIAL SEIZURES
Authors: PRIVITERA M FINCHAM R PENRY JK REIFE R KRAMER L PLEDGER G KARIM R
Citation: M. Privitera et al., DOSE-RANGING TRIAL WITH HIGHER DOSES OF TOPIRAMATE IN PATIENTS WITH RESISTANT PARTIAL SEIZURES, Epilepsia, 36, 1995, pp. 7-7
INCREASED SEIZURE FREQUENCY DURING AND IMMEDIATELY FOLLOWING FELBAMATE WITHDRAWAL
Authors: WELTY TE PRIVITERA M
Citation: Te. Welty et M. Privitera, INCREASED SEIZURE FREQUENCY DURING AND IMMEDIATELY FOLLOWING FELBAMATE WITHDRAWAL, Epilepsia, 36, 1995, pp. 328-328
DIAGNOSTIC SENSITIVITY OF MATERIAL-SPECIFIC MEMORY MEASURES IN MEDICALLY INTRACTABLE SEIZURE PATIENTS
Authors: KIDWELL C SCHEFFT B DUIS C YEH HS PRIVITERA M
Citation: C. Kidwell et al., DIAGNOSTIC SENSITIVITY OF MATERIAL-SPECIFIC MEMORY MEASURES IN MEDICALLY INTRACTABLE SEIZURE PATIENTS, Epilepsia, 36, 1995, pp. 555-555
DIAGNOSTIC SPECIFICITY OF WAIS-R INDEXES IN MEDICALLY INTRACTABLE EPILEPSY PATIENTS
Authors: SCHEFFT B KIDWELL C DUIS C PRIVITERA M YEH HS
Citation: B. Schefft et al., DIAGNOSTIC SPECIFICITY OF WAIS-R INDEXES IN MEDICALLY INTRACTABLE EPILEPSY PATIENTS, Epilepsia, 36, 1995, pp. 568-568
LONG-TERM EFFICACY AND SAFETY OF TOPIRAMATE
Authors: PRIVITERA M
Citation: M. Privitera, LONG-TERM EFFICACY AND SAFETY OF TOPIRAMATE, Epilepsia, 36, 1995, pp. 152-152
LONG-TERM COGNITIVE EFFECTS OF TOPIRAMATE
Authors: PRIVITERA M
Citation: M. Privitera, LONG-TERM COGNITIVE EFFECTS OF TOPIRAMATE, Epilepsia, 36, 1995, pp. 152-152
EEG DETECTION OF NONTONIC-CLONIC STATUS EPILEPTICUS IN PATIENTS WITH ALTERED CONSCIOUSNESS
Authors: PRIVITERA M HOFFMAN M MOORE JL JESTER D
Citation: M. Privitera et al., EEG DETECTION OF NONTONIC-CLONIC STATUS EPILEPTICUS IN PATIENTS WITH ALTERED CONSCIOUSNESS, Epilepsy research, 18(2), 1994, pp. 155-166
IS ERYTHROPOIETIN-INDUCED HYPERTENSION A PHENOMENON DUE TO THE INTRACELLULAR CA++ MOBILIZATION
Authors: BUEMI M ALLEGRA A LAGANA A ALOISI C MORABITO N BALDARI S PRIVITERA M PALELLA S IMBESI D VILLARI C BONANNO N FRISINA N
Citation: M. Buemi et al., IS ERYTHROPOIETIN-INDUCED HYPERTENSION A PHENOMENON DUE TO THE INTRACELLULAR CA++ MOBILIZATION, International angiology, 13(1), 1994, pp. 75-77
MELANCHOLY AND ACEDIA - MARENZIO,LUCA 'SO LO E PENSOSO'
Authors: PRIVITERA M
Citation: M. Privitera, MELANCHOLY AND ACEDIA - MARENZIO,LUCA 'SO LO E PENSOSO', Studi musicali, 23(1), 1994, pp. 29-71
INFLUENCE OF THE TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLASMA-CONCENTRATION OF INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN HEMODIALYZED SUBJECTS
Authors: BUEMI M ALLEGRA A ALOISI C PRIVITERA M MORABITO N FRISINA N
Citation: M. Buemi et al., INFLUENCE OF THE TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLASMA-CONCENTRATION OF INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN HEMODIALYZED SUBJECTS, Nephron, 64(2), 1993, pp. 333-334
Risultati: 1-19 |